The estimated Net Worth of International Group, Inc. A... is at least 279 千$ dollars as of 30 October 2020. International A owns over 625,000 units of SQZ Biotechnologies Co stock worth over 278,500$ and over the last 9 years International sold SQZ stock worth over 0$.
Sign up
International A SQZ stock SEC Form 4 insiders trading
International has made over 1 trades of the SQZ Biotechnologies Co stock since 2020, according to the Form 4 filled with the SEC. Most recently International bought 625,000 units of SQZ stock worth 10,000,000$ on 30 October 2020.
The largest trade International's ever made was buying 52,000,000 units of SQZ Biotechnologies Co stock on 22 July 2016 worth over 2,233,999,999,920,000$. On average, International trades about 3,508,333 units every 0 days since 2015. As of 30 October 2020 International still owns at least 625,000 units of SQZ Biotechnologies Co stock.
You can see the complete history of International A stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's International A's mailing address?
International's mailing address filed with the SEC is 175 Water St, New York, NY 10038, USA.
Insiders trading at SQZ Biotechnologies Co
Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over 3,939$ worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth 35,530,795$ . The most active insiders traders include Holdings (Private) Ltd Temasek、Public Equities, L.P.Minne ...、Amy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of 78,593$. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth 3,939$.
What does SQZ Biotechnologies Co's logo look like?
Complete history of International A stock trades at Tidewater、ClearBridge MLP and Midstream Fund Inc、DNP Select Income Fund、Kayne Anderson Infrastructure Fund Inc、ClearBridge Midstream Opportunity Fund Inc、SQZ Biotechnologies Co
SQZ Biotechnologies Co executives and stock owners
SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:
-
Dr. Armon R. Sharei Ph.D.,
Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director -
Teri Loxam,
Consultant & Advisor -
Dr. Howard Bernstein M.D., Ph.D.,
Chief Scientific Officer -
Lawrence J. Knopf,
Gen. Counsel & Sec. -
Micah Zajic,
Chief Bus. Officer -
Ipsita Roymoulik Ph.D.,
Sr. VP of CMC & QUALITY -
Dr. Marshelle Smith Warren M.D.,
Chief Medical Officer -
David First,
Chief People Officer -
Dr. Howard Bernstein,
Chief Scientific Officer -
Richard V. Capasso CPA,
Chief Accounting Officer -
Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
Co-Founder & Member of Scientific Advisory Board -
Micah Zajic,
Chief Financial Officer -
Howard Phd Md Bernstein,
Interim Chief Executive Office -
Holdings (Private) Ltd Temasek,
10% owner -
Oliver Rosen,
Chief Medical Officer -
Paul Bolno,
Director -
Sapna Srivastava,
Director -
Teri Loxam,
Chief Financial Officer -
Pushkal Garg,
Director -
Klavs F. Jensen,
Director -
International Group, Inc. A...,
10% owner -
Marc Elia,
Director -
David First,
Chief People Officer -
Armon Sharei,
President and CEO -
Amy W Schulman,
Director -
Marc Schegerin,
Director -
Lawrence J Knopf,
General Counsel -
Eric Moessinger,
Director -
Schulman, As Trustee The Ar...,
10% owner -
Public Equities, L.P.Minne ...,
-
Management Co. Vii, L.L.C.P...,
-
Bernard Coulie,
Director -
Patrick V.J.J. Vink,
Director -
Richard Capasso,
See Remarks -
Marshelle Smith Warren,
Chief Medical Officer